Glyco-engineering of biotherapeutic proteins in plants.

Many therapeutic glycoproteins have been successfully generated in plants. Plants have advantages regarding practical and economic concerns, and safety of protein production over other existing systems. However, plants are not ideal expression systems for the production of biopharmaceutical proteins, due to the fact that they are incapable of the authentic human N-glycosylation process. The majority of therapeutic proteins are glycoproteins which harbor N-glycans, which are often essential for their stability, folding, and biological activity. Thus, several glyco-engineering strategies have emerged for the tailor-making of N-glycosylation in plants, including glycoprotein subcellular targeting, the inhibition of plant specific glycosyltranferases, or the addition of human specific glycosyltransferases. This article focuses on plant N-glycosylation structure, glycosylation variation in plant cell, plant expression system of glycoproteins, and impact of glycosylation on immunological function. Furthermore, plant glyco-engineering techniques currently being developed to overcome the limitations of plant expression systems in the production of therapeutic glycoproteins will be discussed in this review.

[1]  N. Itoh,et al.  The structure of a neural specific carbohydrate epitope of horseradish peroxidase recognized by anti-horseradish peroxidase antiserum. , 1991, The Journal of biological chemistry.

[2]  A. von Schaewen,et al.  Isolation and characterization of plant N-acetyl glucosaminyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. , 2000, Plant physiology.

[3]  P. Dupree,et al.  Targeting of Active Sialyltransferase to the Plant Golgi Apparatus , 1998, Plant Cell.

[4]  A. Hiatt,et al.  Production of antibodies in transgenic plants , 1989, Nature.

[5]  R. Reski,et al.  Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. , 2004, Plant biotechnology journal.

[6]  V. Gomord,et al.  Posttranslational modification of therapeutic proteins in plants. , 2004, Current opinion in plant biology.

[7]  R. Kunert,et al.  Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. , 2007, Plant biotechnology journal.

[8]  L. Faye,et al.  The position of the oligosaccharide side-chains of phytohemagglutinin and their accessibility to glycosidases determines their subsequent processing in the Golgi. , 1986, European journal of biochemistry.

[9]  V. Gomord,et al.  Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. , 2005, Vaccine.

[10]  S. Kelm,et al.  Sialic Acids in Molecular and Cellular Interactions , 1997, International Review of Cytology.

[11]  L. Wide.  The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone. , 1986, Acta endocrinologica.

[12]  I. Altosaar,et al.  Sorting of Glycoprotein B from Human Cytomegalovirus to Protein Storage Vesicles in Seeds of Transgenic Tobacco , 2001, Transgenic Research.

[13]  R. Misaki,et al.  Expression of human CMP-N-acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. , 2006, Biochemical and biophysical research communications.

[14]  D. Kuntz,et al.  Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms. , 2003, Biochemistry.

[15]  H. Choy,et al.  Isolation of new CHO cell mutants defective in CMP-sialic acid biosynthesis and transport. , 2006, Molecules and cells.

[16]  Paul Christou,et al.  Genetic modification: The production of recombinant pharmaceutical proteins in plants , 2003, Nature Reviews Genetics.

[17]  S. Jobling,et al.  Immunomodulation of enzyme function in plants by single-domain antibody fragments , 2003, Nature Biotechnology.

[18]  E. Schijlen,et al.  Plant members of the α1→3/4‐fucosyltransferase gene family encode an α1→4‐fucosyltransferase, potentially involved in Lewisa biosynthesis, and two core α1→3‐fucosyltransferases1 , 2001 .

[19]  M. Kaneko,et al.  Interaxonal Eph-Ephrin Signaling May Mediate Sorting of Olfactory Sensory Axons in Manduca sexta , 2003, The Journal of Neuroscience.

[20]  D. M. Lam,et al.  Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Zeleny,et al.  Molecular cloning and characterization of a plant alpha1,3/4-fucosidase based on sequence tags from almond fucosidase I. , 2006, Phytochemistry.

[22]  U. Conrad,et al.  Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity , 1998, Plant Molecular Biology.

[23]  P. Lerouge,et al.  Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. , 2003, Plant biotechnology journal.

[24]  R. Werner,et al.  Glycosylation of therapeutic proteins in different production systems , 2007, Acta paediatrica.

[25]  Paul Chamberlain,et al.  Biopharmaceutical production in plants: problems, solutions and opportunities. , 2005, Trends in biotechnology.

[26]  Pauline M Rudd,et al.  Sugar-mediated ligand-receptor interactions in the immune system. , 2004, Trends in biotechnology.

[27]  P. Lerouge,et al.  Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Lerouge,et al.  Engineering of a sialic acid synthesis pathway in transgenic plants by expression of bacterial Neu5Ac-synthesizing enzymes. , 2007, Plant biotechnology journal.

[29]  A. Vitale,et al.  Transient N-acetylglucosamine in the biosynthesis of phytohemagglutinin: attachment in the Golgi apparatus and removal in protein bodies , 1984, The Journal of cell biology.

[30]  S L Morrison,et al.  Effect of glycosylation on antibody function: implications for genetic engineering. , 1997, Trends in biotechnology.

[31]  S. S. Olmsted,et al.  A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes , 1998, Nature Biotechnology.

[32]  R. Jefferis,et al.  Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. , 1989, The Biochemical journal.

[33]  Pauline M Rudd,et al.  Controlled glycosylation of therapeutic antibodies in plants. , 2004, Archives of biochemistry and biophysics.

[34]  J. Bailey,et al.  Tetracycline-regulated overexpression of glycosyltransferases in Chinese hamster ovary cells. , 1999, Biotechnology and bioengineering.

[35]  D. Bosch,et al.  Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves. , 2001, Plant physiology.

[36]  R. Dwek,et al.  Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals. , 2006, Current opinion in structural biology.

[37]  R. Dwek,et al.  Function and glycosylation of plant-derived antiviral monoclonal antibody , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Faye,et al.  Oligosaccharide Side Chains of Glycoproteins that Remain in the High-Mannose Form Are Not Accessible to Glycosidases. , 1986, Plant physiology.

[39]  P. Lerouge,et al.  Glycoprotein sialylation in plants? , 2004, Nature Biotechnology.

[40]  R. Van Ree,et al.  β(1,2)-Xylose and α(1,3)-Fucose Residues Have a Strong Contribution in IgE Binding to Plant Glycoallergens* , 2000, The Journal of Biological Chemistry.

[41]  Mei-Ping Zhao,et al.  Improvement of the performance of an immunoaffinity extraction method via region-specific immobilization of IgG. , 2006, Journal of chromatography. A.

[42]  B. van den Hazel,et al.  Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. , 2003, The Journal of clinical endocrinology and metabolism.

[43]  P. Lerouge,et al.  N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. , 1997, The Plant journal : for cell and molecular biology.

[44]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[45]  K. Shitara,et al.  Enhancement of the Antibody-Dependent Cellular Cytotoxicity of Low-Fucose IgG1 Is Independent of FcγRIIIa Functional Polymorphism , 2004, Clinical Cancer Research.

[46]  R. Zeleny,et al.  Sialic acid concentrations in plants are in the range of inadvertent contamination , 2006, Planta.

[47]  M. Glogowska,et al.  Inhibition of tumor growth by plant-derived mAb. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C. V. van Dolleweerd,et al.  A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice , 2000, Transgenic Research.

[49]  V. Hascall,et al.  Effect of beta-D-xyloside on the glomerular proteoglycans. I. Biochemical studies , 1984, The Journal of cell biology.

[50]  A. Depicker,et al.  Highly efficient targeting and accumulation of a F(ab) fragment within the secretory pathway and apoplast of Arabidopsis thaliana. , 2001, European journal of biochemistry.

[51]  Markus Aebi,et al.  Altered glycan structures: the molecular basis of congenital disorders of glycosylation. , 2005, Current opinion in structural biology.

[52]  M. Glogowska,et al.  Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Ko,et al.  Plant biopharming of monoclonal antibodies. , 2005, Virus research.

[54]  P. Lerouge,et al.  Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell. , 1999, Plant physiology.

[55]  P. Lerouge,et al.  N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. , 1999, Glycobiology.

[56]  M. Bardor,et al.  A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. , 2006, Plant biotechnology journal.

[57]  P. Lerouge,et al.  Protein Recycling from the Golgi Apparatus to the Endoplasmic Reticulum in Plants and Its Minor Contribution to Calreticulin Retention , 2000, Plant Cell.

[58]  V. Gomord,et al.  Affinity Purification of Antibodies Specific for Asn-Linked Glycans Containing α1 → 3 Fucose or β1 → 2 Xylose , 1993 .

[59]  S. Gillies,et al.  Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function. , 1991, Hybridoma.

[60]  P. Lerouge,et al.  Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. , 2004, Plant biotechnology journal.

[61]  P. Doran,et al.  Characterization of monoclonal antibody fragments produced by plant cells. , 2001, Biotechnology and bioengineering.

[62]  W. Stiekema,et al.  The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco , 1996, Plant Molecular Biology.

[63]  Richard A Lerner,et al.  Expression and assembly of a fully active antibody in algae , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[65]  P. Lerouge,et al.  Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues. , 2004, Plant biotechnology journal.

[66]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[67]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[68]  S. Do,et al.  Increased alpha2,3-sialylation and hyperglycosylation of N-glycans in embryonic rat cortical neurons during camptothecin-induced apoptosis. , 2007, Molecules and cells.

[69]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[70]  P. Lerouge,et al.  Characterization of N-glycans from Arabidopsis. Application to a fucose-deficient mutant. , 1999, Plant physiology.

[71]  T. Lehner,et al.  Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans , 1998, Nature Medicine.